P&G licensing deal
This article was originally published in The Rose Sheet
Executive Summary
GMP Companies will use Procter & Gamble's anti-infective technology to develop antimicrobial hand rub solution and surgical scrub and preparation products under a licensing agreement between the two firms announced Feb. 5. The anti-infective technology comprises a combination of active ingredients not currently available in the health care market, and was found to immediately kill deadly viruses, bacteria and other infectious agents in preliminary testing, firm claims. GMP plans to "broadly commercialize" the technology for use in health care settings, including hospitals and doctors' offices. Under the terms of the agreement, GMP will sell medical formulations of the technology to commercial and industrial customers, while P&G retains the rights to develop and market a retail version. Move is in line with P&G's strategy to license untapped technologies...